MARKET

AVDL

AVDL

Avadel Pharmaceu
NASDAQ
8.12
+0.21
+2.59%
Opening 14:12 04/16 EDT
OPEN
7.88
PREV CLOSE
7.91
HIGH
8.15
LOW
7.75
VOLUME
357.48K
TURNOVER
0
52 WEEK HIGH
19.09
52 WEEK LOW
6.38
MARKET CAP
784.15M
P/E (TTM)
-15.8095
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AVDL last week (0407-0411)?
Weekly Report · 2d ago
AVADEL ANNOUNCES GRANT OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 5d ago
Avadel Pharmaceuticals Price Target Maintained With a $19.00/Share by Needham
Dow Jones · 04/09 10:48
Avadel Highlights Improved Demand for LUMRYZ at Conference
TipRanks · 04/08 19:27
Avadel expects to generate sustainable positive cash flow in 2025
TipRanks · 04/08 17:40
Avadel Pharmaceuticals Provides Update at Needham Virtual Healthcare Conference
Barchart · 04/08 12:30
Weekly Report: what happened at AVDL last week (0331-0404)?
Weekly Report · 04/07 10:04
European pharma evaluates ways to mitigate impact of tariff uncertainty
Seeking Alpha · 04/04 17:58
More
About AVDL
More
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's product, LUMRYZ, is an extended-release formulation of sodium oxybate, indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the challenges patients face with treatment options. Its drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA. Its MICROPUMP technology allows for the development of modified-release solid, oral dosage formulations of drugs. Its LIQUITIME technology allows for the development of modified-release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its MEDUSA technology allows for the development of modified-release injectable dosage formulations of drugs.
Recently
Symbol
Price
%Change

Webull offers Avadel Pharmaceuticals PLC (ADR) stock information, including NASDAQ: AVDL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVDL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVDL stock methods without spending real money on the virtual paper trading platform.